A Clinical Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) for the Evaluation of Efficacy, Safety, Tolerability and Pharmacokinetics in Subjects With Primary Immunodeficiency Diseases (PIDD)
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006623/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to develop a 20% subcutaneous (SC) immunoglobulin preparation
for the treatment of patients with primary immunodeficiency diseases (PIDD).
提供机构：
Vivli
创建时间：
2021-01-27
